These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25201892)

  • 41. Prevalence and correlates of echocardiographic left atrial enlargement in hypertensive outpatients in clinical practice.
    Cuspidi C; Negri F; Lonati L; Muiesan ML; Capra A; Milan A; Sala C; Danzi GB; Longo M; Morganti A;
    Clin Exp Hypertens; 2011; 33(5):328-35. PubMed ID: 21649531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New-onset left atrial enlargement in a general population.
    Bombelli M; Cuspidi C; Facchetti R; Sala C; Tadic M; Brambilla G; Re A; Villa P; Grassi G; Mancia G
    J Hypertens; 2016 Sep; 34(9):1838-45. PubMed ID: 27379539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure.
    Mancia G; Facchetti R; Bombelli M; Grassi G; Sega R
    Hypertension; 2006 May; 47(5):846-53. PubMed ID: 16567588
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Battistelli M; Bartoccini C; Santucci A; Santucci C; Reboldi G; Porcellati C
    J Am Coll Cardiol; 1995 Mar; 25(4):871-8. PubMed ID: 7884090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey).
    Erküner Ö; Dudink EAMP; Nieuwlaat R; Rienstra M; Van Gelder IC; Camm AJ; Capucci A; Breithardt G; LeHeuzey JY; Lip GYH; Crijns HJGM; Luermans JGLM
    Am J Cardiol; 2018 Aug; 122(4):578-583. PubMed ID: 29958714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The aging process of the heart: obesity is the main risk factor for left atrial enlargement during aging the MONICA/KORA (monitoring of trends and determinations in cardiovascular disease/cooperative research in the region of Augsburg) study.
    Stritzke J; Markus MR; Duderstadt S; Lieb W; Luchner A; Döring A; Keil U; Hense HW; Schunkert H;
    J Am Coll Cardiol; 2009 Nov; 54(21):1982-9. PubMed ID: 19909880
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevated left ventricular filling pressure estimated by E/E' ratio after exercise predicts development of new-onset atrial fibrillation independently of left atrial enlargement among elderly patients without obvious myocardial ischemia.
    Takagi T; Takagi A; Yoshikawa J
    J Cardiol; 2014 Feb; 63(2):128-33. PubMed ID: 24012433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Automatically assessed P-wave predicts cardiac events independently of left atrial enlargement in patients with cardiovascular risks: The Japan Morning Surge-Home Blood Pressure Study.
    Yokota A; Kabutoya T; Hoshide S; Kario K
    J Clin Hypertens (Greenwich); 2021 Feb; 23(2):301-308. PubMed ID: 33340234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Left atrial parameters in the estimation of left ventricular filling pressure and prognosis in patients with acute coronary syndrome.
    Hsiao SH; Chiou KR; Porter TR; Huang WC; Lin SK; Kuo FY; Cheng CC; Lin KL; Lin SL
    Am J Cardiol; 2011 Apr; 107(8):1117-24. PubMed ID: 21457807
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of the Increase in Left Ventricular Mass on the Risk of Long-Term Cardiovascular Mortality: A Prospective Cohort Study.
    Bombelli M; Vanoli J; Facchetti R; Maloberti A; Cuspidi C; Grassi G; Mancia G
    Hypertension; 2023 Jun; 80(6):1321-1330. PubMed ID: 37073730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does QRS Voltage Correction by Body Mass Index Improve the Accuracy of Electrocardiography in Detecting Left Ventricular Hypertrophy and Predicting Cardiovascular Events in a General Population?
    Cuspidi C; Facchetti R; Bombelli M; Sala C; Tadic M; Grassi G; Mancia G
    J Clin Hypertens (Greenwich); 2016 May; 18(5):415-21. PubMed ID: 26395327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Left ventricular mass but not geometry determines left atrial size in the early stages of hypertension.
    Tsioufis C; Taxiarchou E; Syrseloudis D; Chatzis D; Tsiachris D; Chatzistamatiou E; Skiadas I; Metallinos G; Tsiamis E; Stefanadis C
    J Hum Hypertens; 2009 Oct; 23(10):674-9. PubMed ID: 19262582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of left atrial strain in predicting cardiovascular morbidity and mortality in the general population.
    Modin D; Biering-Sørensen SR; Møgelvang R; Alhakak AS; Jensen JS; Biering-Sørensen T
    Eur Heart J Cardiovasc Imaging; 2019 Jul; 20(7):804-815. PubMed ID: 30541074
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy.
    Gerdts E; Okin PM; Boman K; Wachtell K; Nieminen MS; Dahlöf B; Devereux RB
    Am J Hypertens; 2012 Jun; 25(6):678-83. PubMed ID: 22456225
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
    Wachtell K; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Nieminen MS; Olsen MH; Okin PM; Palmieri V; Rokkedal JE; Devereux RB
    Blood Press; 2010 Jun; 19(3):169-75. PubMed ID: 20438307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of left atrial reservoir function with left atrial structural remodeling related to left ventricular dysfunction in asymptomatic patients with hypertension: evaluation by two-dimensional speckle-tracking echocardiography.
    Miyoshi H; Oishi Y; Mizuguchi Y; Iuchi A; Nagase N; Ara N; Oki T
    Clin Exp Hypertens; 2015; 37(2):155-65. PubMed ID: 25050647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up.
    Muiesan ML; Salvetti M; Rizzoni D; Monteduro C; Castellano M; Agabiti-Rosei E
    J Hypertens Suppl; 1996 Dec; 14(5):S43-9. PubMed ID: 9120684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients.
    Muiesan ML; Salvetti M; Monteduro C; Bonzi B; Paini A; Viola S; Poisa P; Rizzoni D; Castellano M; Agabiti-Rosei E
    Hypertension; 2004 Apr; 43(4):731-8. PubMed ID: 15007041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study.
    Cuspidi C; Sala C; Casati A; Bombelli M; Grassi G; Mancia G
    Hypertens Res; 2017 Apr; 40(4):329-335. PubMed ID: 27853165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study.
    Meris A; Amigoni M; Uno H; Thune JJ; Verma A; Køber L; Bourgoun M; McMurray JJ; Velazquez EJ; Maggioni AP; Ghali J; Arnold JM; Zelenkofske S; Pfeffer MA; Solomon SD
    Eur Heart J; 2009 Jan; 30(1):56-65. PubMed ID: 19001474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.